A US clinic is harnessing the power of an NVIDIA supercomputer to deliver AI-driven treatments in technology-powered ...

Fintel reports that on June 17, 2025, Wells Fargo downgraded their outlook for Blueprint Medicines (NasdaqGS:BPMC) from Overweight to Equal-Weight. Analyst Price Forecast Suggests 0.45% Downside ...

Fintel reports that on June 2, 2025, JP Morgan downgraded their outlook for Blueprint Medicines (NasdaqGS:BPMC) from Overweight to Neutral. Analyst Price Forecast Suggests 0.02% Downside As of ...

For valuable insights into Blueprint Medicines's market performance, consider these analyst evaluations alongside crucial financial indicators.

PARIS and CAMBRIDGE, Mass., June 2, 2025 /PRNewswire/ -- Sanofi and Blueprint Medicines Corporation (Blueprint), a US-based, publicly traded biopharmaceutical company specializing in systemic ...

Blueprint Medicines Corporation (NASDAQ:BPMC), a commercial-stage biotechnology company specializing in precision therapies for cancer and rare diseases, has been making significant strides in the ...

Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) – Equities researchers at Zacks Research boosted their Q4 2026 earnings per share estimates for Blueprint Medicines in a research note ...

Shareholders of Blueprint Medicines Corporation (NASDAQ:BPMC) will be pleased this week, given that the stock price is up 19% to US$105 following its latest quarterly results. Revenues of US$149m ...

CAMBRIDGE, Mass., May 1, 2025 /PRNewswire/ -- Blueprint Medicines Corporation (Nasdaq: BPMC) today reported financial results, provided a business update for the first quarter ended March 31, 2025 ...

Blueprint Medicines (NASDAQ:BPMC) is gearing up to announce its quarterly earnings on Thursday, 2025-05-01. Here's a quick overview of what investors should know before the release. Analysts are ...

Blueprint Medicines Corporation (NASDAQ:BPMC), a commercial-stage biotech firm with a market capitalization of $5.8 billion specializing in precision therapies for rare diseases, has been making ...